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AIM: To describe the appearance of small solid renal lesions (3 cm) on diffusion-weighted
magnetic resonance imaging (MRI) and to determine whether ADC measurements may help to
differentiate benign from malignant small solid renal masses.
METHODS AND MATERIALS: Thirty-ﬁve patients with 47 small renal masses (23 malignant,
24 benign) who underwent 3 T MRI of the kidney using diffusion-weighted sequences
(b values of 0 and 1000 s/mm2) were retrospectively evaluated. Qualitative and quantitative
analysis of diffusion-weighted images was performed.
RESULTS: Most lesions were hyperintense to kidney on high b-value diffusion-weighted
images and hypointense on apparent diffusion coefﬁcient (ADC) map. The mean ADC of the
lesions was signiﬁcantly lower than that of kidney (1.22  0.3 versus 1.85  0.12 mm2/s;
p < 0.005). The mean ADC was signiﬁcantly different between renal cell carcinomas
(1.2  0.01 mm2/s), metastases (1.25  0.04 mm2/s), angiomyolipoma (1.07  0.3 mm2/s) and
oncocytomas (1.56  0.08 mm2/s; p < 0.05). The mean ADC of clear cell renal cell carcinomas
was signiﬁcantly different from that of non-clear cell renal cell carcinomas (1.38  0.34 versus
0.83  0.34 mm2/s; p < 0.005). No signiﬁcant difference was found between mean ADC of fat
containing and minimal fat angiomyolipomas (1.06  0.48 versus 1.11  0.33 mm2/s).
CONCLUSION: Small solid renal masses are hyperintense on high b value and have different
ADC values.
 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Introduction
The widespread use of ultrasound and computed
tomography (CT) in daily practice for various abdominal
complaints allows for increased incidental discovery of
small solid renalmasses (3 cm) in patients with no urinary
tract symptoms.1 The majority of these masses are malig-
nant, but benign tumours account for 20e25% of all such
masses.2,3 As a consequence, most renal cell carcinomas
(RCC) are now incidentally discovered.4 Differentiation of
benign from malignant lesions is crucial in deciding on
a therapeutic approach.5 Indeed, small malignant renal
masses are usually surgically removed or treated with
minimally invasive percutaneous procedures,6 whereas
benign renal masses are managed conservatively. Small
solid renal masses are known to be difﬁcult to characterize,
except for angiomyolipoma (AML) with large macroscopic
fatty tissue.7 Currently, characterization of renal masses is
based primarily on their appearance on unenhanced CT and
magnetic resonance imaging (MRI; i.e., the presence of
macroscopic fat) and the degree of enhancement at CT and
MRI.8e10 Central stellate ﬁbrosis is seen in only 10% of
* Guarantor and correspondent: F. Agnello. Present address: Diagnostic
and Therapeutic Services, Mediterranean Institute for Transplantation and
Advanced Specialized Therapies (IsMETT), University of Pittsburgh Medical
Center Italy, Via Tricomi 1, 90100 Palermo, Italy. Tel.: þ39 339 46 73 894.
E-mail address: fra.agnello@libero.it (F. Agnello).
Contents lists available at SciVerse ScienceDirect
Clinical Radiology
journal homepage: www.cl inicalradiologyonl ine.net
0009-9260/$ e see front matter  2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.crad.2013.01.002
Clinical Radiology 68 (2013) e301ee308
Author's personal copy
oncocytomas if the lesion is < 3 cm.11 Several diagnostic
clues have been suggested. For example, segmental
enhancement inversion in the corticomedullary and
excretory phases suggests a diagnosis of oncocytoma,12
whereas the presence of an angular interface with the
renal parenchyma is considered a strong predictor of
benignity in an exophytic renal mass.13 However, conven-
tional imaging methods are not speciﬁc enough for differ-
entiating malignant from benign small solid masses6,9,14e17;
therefore, percutaneous renal biopsy is usually recom-
mended to correctly characterize small renal lesions.6
However, this procedure has some limitations: it is not
universally available, and although uncommon, procedural
complications and potential sampling errors can occur.
Several recent studies have shown that diffusion-
weighted imaging (DWI) may help to characterize renal
lesions and to differentiate benign from malignant renal
masses.18e23 However, to the authors’ knowledge, the value
of DWI has not speciﬁcally been studied to characterize small
solid renal masses. Therefore, the purpose of the present
study was to describe the appearance of small solid renal
masses on DWI images and to determine whether apparent
diffusion coefﬁcient (ADC) measurements can aid in differ-
entiating benign from malignant small solid renal masses.
Materials and methods
Study population
The Institutional Review Board approved this study and
informed patient consent was waived.
The electronic database of our department (Department
of Radiology B, Universitary Hospital of Strasbourg, Stras-
bourg, France) was retrospectively reviewed for all MRI
examinations of the kidney between April 2008 and
December 2011 to select patients who presented at least
one solid renal lesion measuring 1e3 cm in maximum
diameter. Lesions of<1 cm in size were excluded in order to
avoid errors due to partial volume effect. A total of 65
patients were identiﬁed. From this initial group of 65, 30
patients were excluded for the following reasons: presence
of infarction, haemorrhage, or infection that could mimic
a solid renal neoplasm (n ¼ 15); no reference standard
(n¼ 10); andMRI artefacts that made the examination non-
diagnostic (n ¼ 5). The remaining 35 patients (mean age
61.6 years; range 27e88 years) were included in the study.
There were 19 men (mean age 60.5 years; range 27e88
years) and 16 women (mean age 61.5 years; range 27e77
years). All patients had a glomerular ﬁltration rate of
30e60 ml/min/m2. Three patients had tuberous sclerosis.
No patient had von HippeleLindau syndrome. In the pres-
ence of multiple renal lesions, a maximum of two was
selected. Thus, 35 patients with 47 lesions were evaluated.
Data collection and reference standard
The standard of reference was the pathological analysis
obtained from ultrasound-guided biopsy with an 18-G
automated device and three cores under 1% lidocaine local
anaesthesia or surgical resection. In fat-containing AMLs for
which histopathological examination was not performed,
the diagnosis was established by using known published
criteria. These included (a) T1 tiny hyperintense spots; (b)
signal loss on fat-saturated images; (c) presence of an ink
artefact on chemical shift sequences; and (d) no change
over time for at least 15 months on MRI follow-up.8
Imaging protocol
All examinations were performed using a 3 T MRI unit
(Achieva, Philips Medical Systems, Best, The Netherlands)
using a dedicated abdominal phased-array coil with 32
coils. The standard protocol included the following
sequences acquired in an axial plane: T2-weighted turbo
spin-echo, fat-saturated T2-weighted turbo spin-echo, T1-
weighted dual gradient-recalled echo, and diffusion-
weighted and three-dimensional fat-saturated dynamic
gadolinium-enhanced T1-weighted gradient-recalled echo.
Dynamic contrast-enhanced images were acquired
before and after the injection of 0.1 mmol gadobenate
dimeglumine (Multihance, Bracco, Milan, Italy) per kilo-
gram of body weight followed by a 20 ml saline ﬂush, both
at 2 ml/s using a power injector (Spectris; Medrad, Pitts-
burgh, PA, USA). The scanning delays were 50, 90, 120, and
180 s after the injection of the contrast material.
A single-shot DWI was obtained before contrast material
administration using echo-planar imaging with a pair of
motion-probing gradients along three orthogonal axes,
chemical shift selective fat-saturation technique, two
b values (0 and 1000 s/mm2), and free breathing. DWI
images were reconstructed for each pixel by using a dedi-
cated post-processing software (diffusion calculation, Ach-
ieva, Version 6.2, Philips Medical Systems), and an ADCmap
was automatically generated to obtain a mono-exponential
ﬁt of the data. MRI parameters are detailed in Table 1.
Imaging analysis
Images were retrospectively and independently evalu-
ated on the workstation of the MRI unit by two radiologists:
a fellow involved in this ﬁeld (F.A.) and an experienced
radiologist with 15 years of experience in abdominal
imaging (C.R.). The readers were unaware of the ﬁnal
diagnosis. Disagreements were discussed and resolved in
consensus. DWI images were evaluated ﬁrst qualitatively
and then quantitatively.
DWI qualitative analysis
Lesions were evaluated on DWI images with b value of
0 and 1000 s/mm2 and on the ADC map on the basis of
signal intensity (SI) relative to the surrounding kidney and
visual degree of SI change with increasing b value. The SI of
the lesions relative to the kidney was classiﬁed into the
following categories: hyperintense, isointense, and hypo-
intense, compared with the surrounding kidney. Visual
degree of SI change with increasing b value was classiﬁed
in the following categories: increasing, similar, or
decreasing.
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DWI quantitative analysis
The mean ADC value was calculated by manually placing
a round or elliptical region of interest (ROI) encompassing
the whole area of the suspected zone on the ADC map. Care
was taken to avoid lesion margins in the ROI in order to
minimize partial volume effects. The mean size of the ROIs
was 3.8  0.6 cm2. One ROI of at least 1 cm2 (mean
1.1  0.4 cm2; range 1e1.8 cm2) was placed in the adjacent
renal parenchyma, at the level of the cortico-medullary
junction.
Statistical analysis
Papillary, chromophobic, and indeterminate RCCs were
combined into one group called non-clear cell (NCC) RCCs
because of the small number of patients. The ADC was
compared among the lesions and the kidney (Man-
neWhitney U-test), among the different types of lesions
(KruskaleWallis test), among clear cell (CC) RCCs and NCC
RCCs (Student’s t-test), and among fat-containing AMLs and
minimal fat AMLs (Student’s t-test). CC RCCs and NCC RCCs
were also analysed as two independent types of lesions and
themean ADC among CC RCCs, NCC RCCs, metastases, AMLs,
and oncocytomas were compared using the KruskaleWallis
test. A p-value of less than 0.05 was considered the
threshold for statistical signiﬁcance. Receiver operating
characteristic (ROC) analysis was done to evaluate the
diagnostic performance of the ADC for differentiating CC
RCCs from NCC RCCs, and from AMLs and oncocytomas, and
for differentiating AMLs from oncocytomas. The optimum
cut-off point was determined as the value that best
discriminated between the types and subtypes in terms of
maximum sensitivity and speciﬁcity.
Results
Lesion characteristics
The ﬁnal study population comprised 47 lesions (mean
diameter 2.1 cm; range 1.1e3 cm). Twenty-three of the 47
(49%) lesions weremalignant (mean diameter 2.1 cm; range
1.2e3 cm) and 24/47 (51%) lesions were benign (mean
diameter 2.1 cm; range 1.1e3 cm). Eighteen lesions were
located in the upper part of the kidney, 17 lesions were
located in the middle part, and 12 lesions were located in
the lower part. Malignant lesions included 19 RCCs (mean
diameter 2.2 cm; range 1.2e3 cm) and four metastases
(mean diameter 1.4 cm; range 1.3e1.6 cm). The primary site
of origin of metastases was lung adenocarcinoma. RCCs
included 13 CC RCCs (mean diameter 2.2 cm; range
1.3e3 cm) and six NCC RCCs (mean diameter 2.3 cm; range
1.2e3 cm). NCC RCCs included three papillary RCCs, one
chromophobic RCC, and two indeterminate RCCs. Benign
lesions included 17 AMLs (mean diameter 2 cm; range
1.1e3 cm) and seven oncocytomas (mean diameter 2.5 cm;
range 1.8e3 cm). AMLs included nine fat-containing AMLs
(mean diameter 20.6 cm; range 1.1e3 cm) and eight
minimal fat AMLs (mean diameter 2 cm; range 1.2e3 cm).
The ﬁnal diagnosis was obtained by surgical resection [10
RCCs (six CC RCCs, four NCC RCCs), ﬁve oncocytomas, four
AMLs (one fat-containing AML, three minimal fat AMLs)],
core-biopsy [nine RCCs (seven CC RCCs, two NCC RCCs), four
metastases, two oncocytomas, ﬁve AMLs (ﬁve minimal fat
AMLs)] and typical MRI appearance in conjunction with
stability in lesion size for at least 15 months (eight fat-
containing AMLs).
DWI qualitative imaging analysis
Results of the qualitative analysis are shown in Table 2.
The image quality was quite good for each case. On these
images, most lesions were hypointense compared with the
kidney on b 0 s/mm2, with an increase of signal intensity on
b 1000 s/mm2 (Figs 5 and 6), whereas only one oncocytoma
was strongly hyperintense on b 0 s/mm2 with a decrease of
signal intensity on b 1000 s/mm2 because of a large central
scar. Except for one CC RCC and one oncocytoma that
showed a moderate hyperintensity, all lesions were hypo-
intense on the ADC map.
DWI quantitative imaging analysis
Mean ADC values of the lesions were signiﬁcantly lower
than those of the kidney [1.22  0.3 (range 0.76e1.90)
versus 1.85  0.12 (range 1.38e2.13); p < 0.005, Man-
neWhitney test; Fig 1]. The mean ADC was signiﬁcantly
different among RCCs (1.2  0.01 mm2/s; range 0.76e1.73),
metastases (1.25  0.04 mm2/s; range 1.1e1.57), AMLs
(1.07  0.3 mm2/s; range 0.85e1.28), and oncocytomas
(1.56  0.08 mm2/s; range 1.1e1.96; p < 0.01,
Table 1
Magnetic resonance imaging (MRI) protocol.
Sequence T2-weighted
TSE
T2-weighted TSE T1-weighted dual GRE DW imaging T1-weighted
3D GRE
Fat suppression No Yes No Yes Yes
TR/TE (ms) 2153/80 1927/80 10/2.3 7099/53 3.4/1.7
Flip angle (degrees) 90 90 15 90 10
Matrix 320  256 321  268 252  188 96  94 252  250
Field of view (mm) 370 370 370 340 370
Section thickness (mm) 5 5 5 5 4
Section gap (mm) 0.5 0.5 0.5 e e
Acquisition time (s) 58 60 76 120 19
TSE, turbo spin echo; GRE, gradient-recalled echo; DW, diffusion-weighted; 3D, three-dimensional; TE, echo time; TR, repetition time.
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KruskaleWallis test; Fig 2). There was a signiﬁcant differ-
ence between mean ADC of CC RCCs (1.38  0.34 mm2/s;
range 1.04e1.73) and NCC RCCs (0.83  0.34 mm2/s; range
0.76e1.01; p < 0.005, Student’s t-test), whereas no signiﬁ-
cant difference was found between mean ADC of fat-
containing AMLs (1.06  0.48 mm2/s, range 0.86e1.28)
and minimal fat AMLs (1.11  0.33 mm2/s; range 1.04e1.22;
p¼ 0.22, Student’s t-test; Fig 3). Therefore, CC RCCs and NCC
RCCs were analysed as two independent types of lesions;
the mean ADC was signiﬁcantly different among CC RCCs,
NCC RCCs, metastases, AMLs, and oncocytomas (p < 0.01,
KruskaleWallis test; Fig 4). The mean ADC value of CC RCCs
was higher than that of AMLs, NCC RCCs and metastases,
and was lower than that of oncocytomas. The best cut-off
ADC values for differentiating CC RCCs from NCC RCCs,
AMLs and oncocytomas were 1.2 mm2/s (AUC ¼ 1.00;
p ¼ 0.00; 100% sensitivity, 100% speciﬁcity); 1.12 mm2/s
(AUC¼ 0.82; p < 0.001; 88% sensitivity, 69% speciﬁcity) and
1.73 mm2/s (AUC ¼ 0.71; p ¼ 0.21; 100% sensitivity, 60%
speciﬁcity), respectively. The best cut-off ADC value for
differentiating AMLs from oncocytomas was 1.21 mm2/s
(AUC ¼ 0.922; p < 0.0001; 86% sensitivity, 88% speciﬁcity).
Discussion
The present study shows that small solid renal masses
with different tissue compositions have different apparent
water diffusion, suggesting that DWI can be used as a non-
invasive procedure to characterize small solid renal masses.
In addition, this sequence can be obtained within a rela-
tively short acquisition time and cannot be considered time
consuming. Few studies have been performed to differen-
tiate renal lesions using the ADC value.12,19e24 These studies
showed that oncocytomas had a higher ADC value than
RCCs, whereas AMLs had a lower ADC value.19e21 In addi-
tion, a recent study by Wang et al.20 indicated that CC RCCs
had a higher mean ADC value than NCC RCCs. However, to
the authors’ knowledge, no previous study has speciﬁcally
analysed the utility of DWI for the characterization of
small solid renal masses deﬁned as 3 cm in maximum
diameter. Similar to other reports, in the present series,
Table 2
Signal intensity of the lesions on DW images and ADC map.
Lesion
type
b 0 seconds/mm2 b 1000 seconds/mm2 SI change at increasing b values ADC map
Hyper Iso Hypo Hyper Iso Hypo Increased Stable Decreased Hyper Iso Hypo
Malignant
lesion
4/23 (17) 0 19/23 (83) 21/23 (91) 1/23 (4) 1/23 (4) 20/23 (87) 3/23 (13) 0 1/23 (4) 0 22/23 (96)
RCCs 4/19 (21) 0 15/19 (79) 17/19 (90) 1/19 (5) 1/19 (5) 16/19 (84) 3/19 (16) 0 1/19 (5) 0 18/19 (95)
CC RCCs 4/13 (30) 0 9/13 (70) 11/13 (84) 1/13 (8) 1/13 (8) 10/13 (77) 3/13 (23) 0 1/13 (8) 0 12/13 (92)
NCC RCCs 0 0 6/6 (100) 6/6 (100) 0 0 6/6 (100) 0 0 0 0 6/6 (100)
Met 0 0 4/4 (100) 4/4 (100) 0 0 4/4 (100) 0 0 0 0 4/4 (100)
Benign
lesions
2/24 (8) 2/24 (8) 20/24 (82) 22/24 (92) 0 2/24 (8) 22/24 (92) 1/24 (4) 1/24 (4) 1/24 (4) 1/24 (4) 22/24 (92)
AMLs 0 1/17 (6) 16/17 (94) 15/17 (88) 0 2/17 (12) 17/17 (100) 0 0 0 0 17/17 (100)
FC AMLs 0 0 9/9 (100) 7/9 (78) 0 2/9 (22) 9/9 (100) 0 0 0 0 9/9 (100)
MF AMLs 0 1/8 (12) 7/8 (88) 8/8 (100) 0 0 8/8 (100) 0 0 0 0 8/8 (100)
Onc 2/7 (28) 1/7 (14) 4/7 (58) 7/7 (100) 0 0 5/7 (72) 1/7 (14) 1/7 (14) 1/7 (14) 1/7 (14) 5/7 (72)
Data are numbers of lesions. Data in parentheses are percentages.
SI, signal intensity; hyper, hyperintense; iso, isointense; hypo, hypointense; RCCs, renal cell carcinomas; CC RCCs, clear cell type renal cell carcinomas; NCC
RCCs, non-clear cell type renal cell carcinomas; met, metastases; AMLs, angiomyolipomas; FC AMLs, fat containing angiomyolipomas; MF AMLs, minimal fat
angiomyolipomas; onc, oncocytomas.
Figure 1 Box-and-whisker plot of ADC values of renal lesions and
uninvolved renal parenchyma. Horizontal line in each box is the
median ADC value. Upper and lower margins of the box represent
75th and 25th percentile of values, respectively. Whiskers give range
of values.
Figure 2 Box-and-whisker plot of ADC values of oncocytomas (onc.),
metastases (met), RCCs, and AMLs. Horizontal line in each box is the
median ADC value. Upper and lower margins of the box represent
75th and 25th percentile of values, respectively. Whiskers give range
of values.
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malignant lesions, such as RCCs and metastases had inter-
mediate ADC values between those of AMLs and oncocy-
tomas.22,24 These results can be explained by the different
histological architecture of these masses, as ADCs reﬂect the
combined effects of capillary perfusion and diffusion.25
AMLs contain varying amounts of fatty, angiomatous, and
myomatous components, with an interstitial stroma that
reduces water diffusion.21,26 Oncocytomas are composed of
eosinophilic cells (oncocytes) arranged in a variety of
growth patterns, with a central ﬁbrotic scar containing
compressed blood vessels.8 RCCs are a heterogeneous group
of tumours characterized by different genetic andmolecular
abnormalities.20 Four main subtypes of RCCs are described
in the literature: clear cell, papillary, chromophobic, and
indeterminate.27 An accurate differentiation of these
subtypes is crucial because CC RCCs are associated with
a poorer prognosis than NCC RCCs, with the exception of
indeterminate RCCs, which are less frequent than other
subtypes.22,28 In the present study, NCC RCCs had a lower
ADC value than CC RCCs. A threshold value of 1.2 mm2/s
allowed a differential diagnosis with high sensitivity and
speciﬁcity. This can be explained by the different histolog-
ical architecture of CC RCCs and NCC RCCs, as the latter
contain small vessels without arterio-venous shunts.27 A
decreased perfusion could partially explain the decreased
ADC. Contrary to other reports, in the present series, NCC
RCCs had a mean ADC value that was lower than that of
other small renal masses, AMLs included. In the literature,
there is no consensus on the optimal b-value to be used at
DWI.20,21 High b-values increase diffusionweighting and, in
theory, tumour detection, especially at 3 T. The ADC value is
potentially an objective mean, but despite there being no
ofﬁcial cut-off for tumours, the value of 1000 mm2/s
seems a reasonable threshold. It is unclear why there is
a discrepancy between the present observations and
previous reports. However, if the present ﬁndings were to
be conﬁrmed in a larger series, it could be extremely
important diagnostically. In view of ﬁndings of Zhang
et al.,29 it can be hypothesized that, because the main
drawback of DWI is the lack of standardization, the vari-
ability of ADC values can probably be explained by differ-
ences in b values, coil systems, breath-hold versus free
breathing, and ﬁeld strengths used for MRI. Another inter-
esting ﬁnding of the present study is the absence of
a signiﬁcant difference in mean ADC between fat-
containing AMLs and minimal fat AMLs. Fat-containing
AMLs can be easily identiﬁed with conventional MRI
sequences,8 but the present results indicate that DWI can be
an interesting sequence to suggest a benign lesion in the
case of minimal fat AMLs. However, it should be noted that
overlap among ADC values between small solid renal
masses was observed in the present series. This limits the
applicability of ADC measurements for lesion characteriza-
tion. For this reason, DWI could not be used as a standalone
sequence for the characterization of small renal masses, and
ADC values should be concurrently interpreted with all
available images to avoid misinterpretation.
The present study shows that small renal masses have
a lower ADC than the normal surrounding parenchyma
(1.22  0.27 versus 1.85  0.12). These results are in
agreement with a study by Cova et al.,24 who found higher
ADC values in renal parenchyma compared with solid renal
lesions (2.19  0.17 versus 1.55  0.2).
A qualitative analysis of the lesions on DW images and
ADC map was also performed. The present study demon-
strates that almost all small solid renal masses show high
signal intensity on higher b values and low signal intensity
on the ADC map, when compared with normal renal
parenchyma. Thus, the visual evaluation of DWI images is
pertinent because of the high contrast with the surrounding
parenchyma, and can be useful for the detection of small
renal masses. These observations corroborate the results of
a recent study by Blackledge et al.30 on lesion detectionwith
Figure 3 Box-and-whisker plot distribution of ADC values of AML subtypes (a) and RCC subtypes (b). Horizontal line in each box is the median
ADC value. Upper and lower margins of the box represent 75th and 25th percentile of values, respectively. Whiskers give range of values.
Figure 4 Box-and-whisker plot of ADC values of oncocytomas (onc),
AMLs, CC RCCs, NCC RCCs, and metastases (met). Horizontal line in
each box is the median ADC value. Upper and lower margins of the
box represent 75th and 25th percentile of values, respectively.
Whiskers give range of values.
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high b values DWI.30 In addition, visual assessment is useful
in differentiating solid from cystic lesions. Of note, in the
present series, two AMLs were hypointense on b 0 and
b 1000, though they showed a mild increase in signal
intensity with increasing b value. This could be related to
the fact that restriction of diffusion may not be sufﬁcient to
make the lesions hyperintense to kidney at high b value.
Furthermore, as DWI is actually part of the routine MRI
protocol in many centres, radiologists should keep in mind
that most solid benign lesions are hyperintense at high
b values and that hypointensity on the ADC map is not
imperatively associated with malignancy.
The present study had several limitations. First, the
number of lesions was relatively small in each group and
subgroup. Moreover, there was a potential selection bias in
the study, with 10 patients excluded because they had
a small renal mass, but no sufﬁcient conﬁrmation of the
nature of the lesion (i.e., lack of reference standard).
Therefore, the present ﬁndings need to be conﬁrmed in
larger series. Second, pseudo-lesions (e.g., infarction, hae-
morrhage, or infection) were not evaluated in the study,
which limits the ability to assess false-positive ﬁndings.
Third, a mono-exponential assessment of ADC was used
and, therefore, physiological processes, such as pure diffu-
sion of water molecules and perfusion, may affect the
estimation of ADC. A bi-exponential model based on
multiple b value measurements is known to be better for
ADC measurements. However, this latter solution is not
practical in clinical use.29 Last, because of the aim of the
study, diffusion-weighted sequences were not compared
with T2-weighted sequences and contrast-enhanced T1-
weighted sequences for the detection and characterization
of small solid renal lesions.
In conclusion, small solid renal masses with different
tissue composition were found to be hyperintense on high
b values and have different ADC values. This suggests that
DWI can provide supporting information for detecting and
characterizing small solid renal masses. However, as some
Figure 5 CC RRC in a 73-year-old man. (a) Axial T2-weighted image shows a heterogeneously hyperintense lesion due to some hyperintense
areas. (b, c) Axial DWI images with b values of 0 (b) and 1000 (c) s/mm2: the lesion is heterogeneously hypointense at b0 s/mm2 and heter-
ogeneously hyperintense at b 1000 s/mm2. Areas with increase in signal intensity at b 1000 indicate restricted diffusion. (d) Corresponding ADC
map shows a heterogeneously hypointense lesion compared with kidney. Lesion ADC is 1.43  103 mm2/s. Kidney ADC is 1.95  103 mm2/s.
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overlaps among ADC values of small solid renal masses
occur, DWI cannot be used as a standalone sequence for
lesion characterization, and ADC values should be concur-
rently interpreted with all available images to avoid
misinterpretation.
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